EXCLUSIVE LIFE SCIENCE FEATURE
REPORT
12
LIFESCIENCELEADER.COM JULY 2014 CMO SUPPLEMENT
The latest industry trends and proprietary data from Nice Insight survey results.
■ Biotech ■ Emerging Biotech ■ Big Pharma ■ Specialty Pharma ■ Emerging Pharma
■ Biotech ■ Emerging Biotech ■ Big Pharma ■ Specialty Pharma ■ Emerging Pharma
Large Molecule API
& Biologics
Large Molecule API
& Biologics
Injectables Product
Development
Solid Dosage Forms
Other Delivery
Forms (Inhalable/
Transdermal)
Semi-Solids
& Liquids
Solid Dose,
Semi-Solids,
& Liquid
Development
Injectables
Small Molecule
API
Small Molecule
API & Advanced
Intermediates
■ 60%
■ 96%
■ 67%
■ 43%
■ 53%
■ 46%
■ 61%
■ 49%
■ 39%
■ 54%
■ 44%
■ 61%
■ 52%
■ 71%
■ 43%
■ 51%
■ 48%
■ 53%
■ 61%
■ 75%
■ 65%
■ 43%
■ 65%
■ 48%
■ 63%
■ 36%
■ 23%
■ 46%
■ 32%
■ 33%
■ 25%
■ 7%
■ 31%
■ 24%
■ 20%
■ 43%
■ 71%
■ 43%
■ 43%
■ 42%
■ 58%
■ 89%
■ 53%
■ 57%
■ 43%
■ 56%
■ 65%
■ 59%
■ 64%
■ 58%
Specialty
Dosage Forms
■ 36%
■ 68%
■ 47%
■ 46%
■ 38%
0 7 1 4 _ R e s e a r c h _ R e p o r t s _ O I _ O n c o l o g y 2 . i n d d 4 0714_Research_Reports_OI_Oncology2.indd 4 6 / 2 3 / 2 0 1 4 2 : 2 9 : 0 2 P M 6/23/2014 2:29:02 PM